Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Active not recruiting 5Unknown 4Terminated 3Recruiting 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 1Parkinson Disease 1Glioma 1

Interventions

Gemcitabine 13Specimen Handling 12Radiotherapy 12Androgen Antagonists 12Magnetic Resonance Spectroscopy 10Nivolumab 9pembrolizumab 8darolutamide 7Drug Therapy 7toripalimab 6Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Ipilimumab 4Cyclophosphamide 4Biopsy 4Axitinib 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Positron Emission Tomography Computed Tomography × Genitourinary × Clear all
NCT06914427 2025-04-06

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Xijing Hospital

Phase NA Not yet recruiting
35 enrolled
CNSGenitourinary

Glioma, Parkinson Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡